ArticleFrontiers in cardiovascular medicine2026
The association between coronary microvascular dysfunction and HbA1c in patients with unstable angina pectoris.
Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Angiographic microvascular resistance (AMR) is an effective parameter for assessing coronary microcirculatory function, and studies have indicated its association with adverse cardiovascular outcomes. However, the relationship between glycemic metabolic status and AMR levels requires further investigation. Methods: A total of 291 patients with unstable angina who underwent percutaneous coronary intervention (PCI) in the Cardiology Department of the Second Affiliated Hospital of Xuzhou Medical University from December 2022 to December 2023 were consecutively included, Based on the status of coronary microcirculation function, the enrolled patients were divided into a non-coronary microcirculation dysfunction group ( Results: Compared to the non-coronary microcirculation dysfunction group, the coronary microcirculation dysfunction group had a higher proportion of female patients and higher levels HbA1c ( Conclusions: The HbA1c level is independently linked to a higher risk of post-PCI CMD.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.